ARTICLE | Clinical News
DuoPlavin/DuoCover clopidogrel/acetylsalicylic acid regulatory update
January 4, 2010 8:00 AM UTC
EMEA's CHMP issued a positive opinion on an MAA from Bristol-Myers for DuoPlavin/DuoCover, a fixed-dose combination of clopidogrel and acetylsalicylic acid to prevent atherothrombotic events. Bristol-...